Participants of our startup programs in the News!
InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and assessment of organotypic 3D cell culture models, met with members of the United States House of Representatives to discuss advances in in vitro research technology that can help reduce the use of animals in research.
Cyberhaven (Venture Leaders 2013 participants under the name of iQA), a stealth-mode cybersecurity startup spun out of the Swiss Federal Institute of Technology in Lausanne (EPFL), announced that it closed over $2 million in an oversubscribed first round of financing. They’ve opened a second office in Boston.
BestMile, the Lausanne based startup specialising in software to manage driverless vehicle fleets remotely, announces the closing of $2.5M in seed round led by an angel investor from the Zurich region. The funds will be used to rapidly scale the team internationally, accelerate development and boost growth. Bestmile was a participant of the 2015 Venture Leaders Program.
The 2014 venture leaders participant closed a $4.3M Series A to build safer drones for inaccessible places.
May 2016 – Polyneuron, a University of Basel spin-off, is developing a compound for the treatment of autoimmune disorders. The substances developed on the Antibody-Catch technology platform block specific antibodies that attack the body’s own tissue. Now, the 2015 Venture Leaders participants, completed a financing round raising over CHF 3 million with a group of private investors together with early investors such as the EVA Basel and the ZKB.
May 2016 – Flatev has created a fresh tortilla maker that enables you to cook the perfect tortilla with all the freshness, texture and consistency of the traditional homemade style in less than 2 minutes. May 3rd, the Swiss startup and participant of our Venture Leaders program has launched a 30-day campaign on Kickstarter to help cover manufacturing costs on. They reached their funding goal in less than three ours!
May 2016 – Abionic, a EPFL-spinoff and participant of our CTI Market Entry CAMP, is among the finalists for the SEF Award, given by the Swiss Economic Forum to young Swiss entrepreneurs. The Award ceremony will take place in June. Based on a disruptive nanotechnology, Abionic is committed to revolutionize the world of in vitro diagnostics with rapid universal point-of-care solutions
BuddyBrokers AG / Equipia
April 2016 – Venture Leaders 2015 participant BuddyBrokers, along with their recruiting tool Equipia, has been bought by XING AG for CHF 3.2 million. The two co-founders, Furin Müller and Patrick Mollet are staying with the company.
via venturelab (German only)
March 2016 – Amal Therapeutics (Amal) completes CHF 3 million (EUR 2.75 million) Series A financing round with Boehringer Ingelheim Venture Fund (BIVF) as cornerstone investors. VI Partners and High-Tech Gründerfonds also participated in the round which will help progress Amal’s cancer vaccines.
Feb 2016 – Simone Bottan from HYLOMORPH, an ETH Zurich Spin-off and participant of the 2015 Venture Leaders Team, is one of two winners in the Venture Kick Final, taking away an award of 130’000 CHF.
Jan 2016 – Biognosys, a Swiss next-generation proteomics company and current participant of our CTI market entry CAMP, has secured significant funding from a corporate investment fund. The company is using the Series C financing round to establish business development and service operations in the US and to develop new workflows and products for high-content protein analysis.
via swissnex Boston (Source: Biognosys)
Jan 2016 – Goodwall, participant of our CTI camp, has closed a financing round of 2.1 million Swiss Francs and is currently looking at more than 500’000 registered students! The Geneva based startup is focusing their work on the academic landscape in North America and Great Britain and is hoping to have 1-2 million students registered by the end of 2016.
Dec 2015 – Relief Therapeutics SA, participants of the 2013 Venture Leaders program, has finalized a tripartite binding agreement with THERAMetrics holding and GEM Funds. This will result in the creation of a new biotechnology company having access to the public market to valorise a portfolio composed of innovative clinical programs. Indeed, the combined company will take advantage of the significant financing commitment of GEM Funds to resume the clinical developments of several medicinal product candidates, e.g. atexakin alfa targeting peripheral neuropathies and aviptadil for the treatment of various pulmonary pathologies.
Nov 2015 – After a first round completed in January 2015, the Venture Kick final winner and TOP 10 Swiss Startup 2015 Flyability, based in Lausanne, is proud to announce the completion of its second seed funding round. Congratulations to our Venture Leaders 2015 participants!
Nov 2015 – Faceshift, a Zurich based spinoff of Ecole polytechnique fédérale de Lausanne (EPFL) has been acquired by Apple Inc.. A 201x participant of the Venture Leaders program has developed technology to create animated avatars and other figures that capture a person’s facial expressions in real time.
Nov 2015 – Bestmile, participants of the Venture Leaders 2015 program, has signed its first commercial contract with CarPostal, the major public transport operator in Switzerland. This collaboration between the EPFL spin-off and the subsidiary of the Swiss Post will allow to operate autonomous vehicles in urban areas.
Oct 2015 – Dacuda, former participant of our Venture Leaders Program and now a world-leading provider of computer vision technologies for 2D and 3D imaging, has unveiled the vision for its software 3D camera technology. The technology is able to turn any phone into a powerful 3D scanner that brings capabilities, comparable to time-of-flight or structured light hardware 3D cameras, to every consumer.